More robust analytical evidence should support the selection of human chorionic gonadotropin assays for oncology application. [electronic resource]
Producer: 20200826Description: e61-e63 p. digitalISSN:- 1437-4331
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.